Biomotion Sciences Ordinary Shares (SLXN : NASDAQ)
Common Stock
$0.54
USD
+0.11 (24.77%)
Last updated: 2026-09-21
Get SLXN alerts:
SLXN
Biomotion Sciences Ordinary Shares
WealthAwesomePerformance
1 Day
+24.77%
1 Week
+41.30%
1 Month
+38.07%
YTD
-81.24%
Key Statistics
Market Cap
$2.42M
52W High
$42.60
52W Low
$0.32
P/E Ratio
-
50 Day MA
$1.21
200 Day MA
$10.32
Beta
-0.36
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/21/2026 | $0.42 | $0.63 | $0.41 | $0.54 | $0.54 | 19,762,100 |
| 9/18/2026 | $0.39 | $0.45 | $0.38 | $0.44 | $0.44 | 27,064,700 |
| 9/17/2026 | $0.37 | $0.39 | $0.35 | $0.38 | $0.38 | 8,402,200 |
| 9/16/2026 | $0.34 | $0.35 | $0.32 | $0.34 | $0.34 | 2,401,600 |
| 9/15/2026 | $0.34 | $0.35 | $0.32 | $0.34 | $0.34 | 36,968,300 |
| 9/14/2026 | $0.35 | $0.40 | $0.34 | $0.39 | $0.39 | 888,200 |
| 9/11/2026 | $0.36 | $0.39 | $0.34 | $0.36 | $0.36 | 2,578,200 |
| 9/10/2026 | $0.41 | $0.49 | $0.39 | $0.42 | $0.42 | 118,949,200 |
| 9/9/2026 | $0.34 | $0.36 | $0.34 | $0.35 | $0.35 | 66,900 |
| 9/8/2026 | $0.36 | $0.36 | $0.34 | $0.34 | $0.34 | 189,000 |
Analyst Price Targets
Based on 1 analyst covering SLXN · as of Sep 17, 2026
Wall Street analysts forecast SLXN stock price to rise 10929.4% over the next 12 months.
Consensus
Buy4.00 / 5.00
Avg. Target
US$60.00
+10929.4% Upside
Current Price
US$0.54
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SLXN's historical volatility
30-Day Vol
294.8%
Annualized
90-Day Vol
223.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$0.46
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$0.51 | US$0.19 – US$1.42 |
| 60 trading days | US$0.48 | US$0.11 – US$2.04 |
| 90 trading days | US$0.46 | US$0.08 – US$2.65 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Biomotion Sciences Ordinary Shares
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-14.12M
- Profit Margin
- 0.00%
- ROE (TTM)
- -897.46%
- EPS (Diluted)
- -19.89
- Book Value
- 0.01
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About SLXN.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GRML | Greenland Mines Ltd | $9.42 | +230.53% |
| GLND | Greenland Energy Company Common Stock | $2.88 | +140.00% |
| BTTC | Black Titan Corporation | $0.79 | +117.75% |
| VEEE | Twin Vee Powercats Co | $17.24 | +100.93% |
| VRME | VerifyMe Inc | $1.38 | +73.58% |
| AVAT | Avalanche Treasury Corporation Class A Common Stock | $1.87 | +73.15% |
| INV | Innventure, Inc. | $0.88 | +47.26% |
| SVRN | OceanPal Inc. | $29.50 | +45.18% |